Ahead of Earnings: Tilray Brands, Accolade, and AngioDynamics in the Spotlight
- September 30th, 2023
- 542 views
Some of the companies expected to report financial results on Wednesday, October 4, are:
Tilray Brands, Inc. (Nasdaq: TLRY), a company in the cannabis industry, is scheduled to release its first-quarter fiscal 2024 financial results before the market opens.
Analysts are forecasting a loss of $0.05 per share on revenue of $174 million.
On Friday, $TLRY closed at $2.39, up $0.04 (+1.70%).
Accolade, Inc. (Nasdaq: ACCD), a provider of personalized healthcare solutions, will unveil its fiscal second-quarter 2024 financial results after the market closes.
The consensus estimate points to a loss of $0.54 per share, accompanied by revenue reaching $94.09 million.
$ACCD closed at $10.58 on Friday, reflecting a decrease of $0.18 (-1.67%).
AngioDynamics, Inc. (Nasdaq: ANGO), a medical device company, is set to report financial results for the first quarter of fiscal year 2024 before the market opens.
Analysts expect a loss of $0.13 per share on revenue of $77.69 million.
On Friday, $ANGO closed at $7.31, down $0.01 (-0.14%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026
Member Login